EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Topical chamomile oil as a novel therapeutic intervention for diabetic neuropathy: A randomized double-blind controlled clinical trial

Mohammad Amiri, Mohammad Hossein Imani, Amir Hossein Imani, Hanieh Bazrafshan, Mehdi Bazrafshan, Hossein Molavi Vardanjani, Mohammad Ebrahim Zohalinezhad

EXPLORE · 2025

DOI: 10.1016/j.explore.2025.103189 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift EXPLORE, 2025. Verfasst von Mohammad Amiri und 6 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Traditional Medicine and History of Medicine, Department of Persian Medicine, School of Medicine, Shiraz University of Medical Sc…. Hauptthemen laut MEDLINE: Diabetic Neuropathies, Chamomile, Plant Oils. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: Shiraz University of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Diabetic neuropathy, a prevalent complication of diabetes mellitus, significantly impairs quality of life due to chronic pain and sensory deficits. Conventional pharmacotherapies, while effective, are often limited by systemic adverse effects. Chamomile (Matricaria chamomilla L.) oil, renowned for its anti-inflammatory, antioxidant, and analgesic properties, presents a promising topical alternative for mitigating neuropathic symptoms. OBJECTIVE: This study aimed to evaluate the efficacy of topical chamomile oil in improving neuropathy indices among patients with controlled diabetes, as measured by validated clinical tools. METHODS: A randomized, double-blind, placebo-controlled trial was conducted involving 72 participants with diabetic neuropathy. Participants were allocated to either the intervention group (chamomile oil) or the control group (placebo), with both groups continuing standard gabapentin therapy. Neuropathy outcomes were assessed using Neurothesiometer scores, the Michigan Neuropathy Screening Instrument (MNSI), and the DN4 questionnaire at baseline and post-intervention. ANCOVA was employed to analyze intergroup differences, adjusting for baseline covariates. RESULTS: The chamomile oil group exhibited statistically significant improvements in neuropathy indices compared to the placebo group (p < 0.05). Post-intervention, reductions in Neurothesiometer scores (mean difference: -1.14 ± 0.42), MNSI (-1.89 ± 0.31), and DN4 (-1.97 ± 0.28) were observed in the intervention group, with no comparable changes in controls. ANCOVA confirmed the robustness of these findings (F = 6.72, p = 0.012). CONCLUSION: Topical chamomile oil significantly alleviates neuropathic symptoms in diabetic patients, offering a safe and adjunctive therapeutic option. Its mechanism may involve modulation of oxidative stress and inflammatory pathways, warranting further investigation into long-term benefits and molecular targets. TRIAL REGISTRATION: This trial was registered at the Iranian Registry of Clinical Trials (IRCT), registration number IRCT20240611062090N1. The full protocol is available at www.irct.ir.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NeuropathiesChamomilePlant OilsHumansDouble-Blind MethodMaleFemaleMiddle AgedAdultAgedAdministration, TopicalQuality of LifeGabapentin

Stichwörter der Autor:innen

Chamomile oilDN4 questionnaireDiabetic neuropathyMNSINeurothesiometerTopical treatment

Substanzen

Plant OilsGabapentin

Autor:innen und Institutionen

  • Research Center for Traditional Medicine and History of Medicine, Department of Persian Medicine, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran; Student research committee, School of Medicine,…
  • Student research committee, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
  • School of Medicine, Iran university of medical sciences, Tehran, Iran.
  • Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Cardiovascular Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
  • MD-MPH Department, School of Medicine, Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. Electronic address: hosseinmolavi@ymail.com.

Förderung

  • Shiraz University of Medical Sciences

Zitieren

APA

Amiri, M., Imani, M. H., Imani, A. H., Bazrafshan, H., Bazrafshan, M., Vardanjani, H. M., & Zohalinezhad, M. E. (2025). Topical chamomile oil as a novel therapeutic intervention for diabetic neuropathy: A randomized double-blind controlled clinical trial. EXPLORE. https://doi.org/10.1016/j.explore.2025.103189

Vancouver

Amiri M, Imani MH, Imani AH, Bazrafshan H, Bazrafshan M, Vardanjani HM, et al. Topical chamomile oil as a novel therapeutic intervention for diabetic neuropathy: A randomized double-blind controlled clinical trial. EXPLORE. 2025. doi:10.1016/j.explore.2025.103189

BibTeX
@article{Amiri2025,
  author = {Amiri, Mohammad and Imani, Mohammad Hossein and Imani, Amir Hossein and Bazrafshan, Hanieh and Bazrafshan, Mehdi and Vardanjani, Hossein Molavi and Zohalinezhad, Mohammad Ebrahim},
  title = {Topical chamomile oil as a novel therapeutic intervention for diabetic neuropathy: A randomized double-blind controlled clinical trial},
  journal = {EXPLORE},
  year = {2025},
  doi = {10.1016/j.explore.2025.103189}
}
Kostenlos starten →